Denodo University Challenge Now Open: Data and AI for Real-World Impact
Notified -
Globe Newswire2-06-2025, 18:00
Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis 26-02-2024, 14:05